Mouse models of human neurodegenerative disorders: Requirements for medication development

Archives of Neurology

Volumn 62, Issue 2, 2005, Pages 185-187

  Bloom, Floyd E ^a   Reilly, John F ^a   Redwine, Jeff M ^a   Wu, Chi Cheng ^a   Young, Warren G ^a   Morrison, John H ^b  

^a Neurome Inc   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ALZHEIMER DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; DEGENERATIVE DISEASE; DISEASE COURSE; FAMILIAL DISEASE; GENE EXPRESSION; GENE IDENTIFICATION; GLIA; HUMAN; NERVE CELL; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, TRANSGENIC; NEURODEGENERATIVE DISEASES;

EID: 13444301296     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.62.2.185     Document Type: Review

References (10)

1. Dodart JC, Mathis C, Bales KR, Paul SM. Does my mouse have Alzheimer's disease? Genes Bain Behav. 2002;1:142-155.
2. Dickson DW. Building a more perfect beast: APP transgenic mice with neuronal loss. Am J Pathol. 2004;164:1143-1146.
3. Buttini M, Yu GQ, Shockley K, et al. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation. J Neurosci. 2002;22:10539-10548.
4. Kulnane LS, Lamb BT. Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice. Neurobiol Dis. 2001;8:982-992.
5. Lewis J, Dickson DW, Lin WL, et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 2001;293:1487-1491.
6. Richardson JC, Kendal CE, Anderson R, et al. Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer's disease. Neuroscience. 2003;122:213-228.
7. Rothstein JD. Of mice and men: reconciling preclinical ALS mouse studies and human clinical trials. Ann Neurol. 2003;53:423-426.
8. Redwine JM, Kosofsky B, Jacobs RE, et al. Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: a magnetic resonance microscopy and stereologic analysis. Proc Natl Acad Sci U S A. 2003;100:1381-1386.
9. Reilly JF, Games D, Rydel RE, et al. Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model. Proc Natl Acad Sci U S A. 2003;100:4837-4842.
10. Wu CC, Chawla F, Games D, et al. Selective vulnerability of dentate granule cells prior to amyloid deposition in PDAPP mice: digital morphometric analyses. Proc Natl Acad Sci U S A. 2004;101:7141-7146.